0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Integrin alpha V beta 3

Integrin alpha V beta 3

Brief Information

Name:Integrin alpha-V/beta-3
Target Synonym:Integrin alphaVbeta3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
IT3-H52E3 Human Human Integrin alpha V beta 3 (ITGAV&ITGB3) Heterodimer Protein, His Tag&Tag Free (MALS verified)
IT3-H52E3-structure
IT3-H52E3-sds
IT3-H52E3-elisa_1

Part of Bioactivity data

IT3-H52E3-MALS-HPLC
Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. ) MALS images

The purity of Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) was more than 85% and the molecular weight of this protein is around 207-253 kDa verified by SEC-MALS.

Bioactivity-ELISA
Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag FreeHuman ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) ELISA bioactivity

Immobilized Human Fibronectin at 2 μg/mL (100 μL/well) can bind Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) with a linear range of 0.01-0.3 μg/mL (QC tested).

IT3-H52E3-ELISA
Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag FreeHuman ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) ELISA bioactivity

Immobilized Human Fibronectin at 2 μg/mL (100 μL/well) can bind Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) with a linear range of 0.01-0.3 μg/mL (QC tested).

Synonym Name

Integrin alpha V beta 3,ITGAV&ITGB3,ITGAV&B3

Background

Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Also, Integrin alpha-V/beta-3 acts as a receptor for herpes virus 8/HHV-8, coxsackievirus A9, Hantaan virus, cytomegalovirus/HHV-5, human metapneumovirus, human parechovirus 1 and west nile virus. Furthermore, in case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
68Ga-NOTA-BBN-RGD 68Ga-NOTA-BBN-RGD Phase 1 Clinical Peking Union Medical College Hospital Breast Neoplasms; Prostatic Neoplasms Details
68Ga-NOTA-3PTATE-RGD 68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD Phase 1 Clinical Peking Union Medical College Hospital Lung Neoplasms Details
SF-0166 SF-0166 Phase 2 Clinical Scifluor Life Sciences Diabetic macular oedema; Macular Degeneration Details
Peptide-based PET radiotracer (Stanford University) Phase 2 Clinical Stanford University Neoplasms Details
IDL-2965 IDL-2965 Phase 2 Clinical Indalo Therapeutics Non-alcoholic Fatty Liver Disease; Idiopathic Pulmonary Fibrosis Details
Abituzumab DI-17E6; EMD-525797 Phase 2 Clinical Merck Serono Bone metastases; Solid tumours; Scleroderma, Systemic; Ovarian Diseases; Prostatic Neoplasms; Colorectal Neoplasms Details
AS-101 WAX-120337; IVAX-Q-101; IVX-Q-101; CB-06-02; AS-101; PRX-001; PRX-0002/AS101; PRX-0001/AS101 Phase 2 Clinical Biomas Warts; Myelodysplastic Syndromes; Psoriasis; Leukemia, Myeloid, Acute; Thrombocytopenia; Macular Degeneration; Condylomata Acuminata; Dermatitis, Atopic Details
Antiangiotide HM-3; IIM-3 Phase 1 Clinical Neimenggu Tianqi Mnegyao Group Co Ltd, China Pharmaceutical University Liver Neoplasms; Solid tumours; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Alfatide[18F] Phase 1 Clinical Taizhou Kairui Pharmaceutical Technology Co Ltd, Jiangsu Smk Pharmaceutical Co Ltd Neoplasms Details
派格安替安吉肽 Phase 1 Clinical Nanjing Anji Biological Technology Co Ltd, Jiangsu Aotexin Biomedical Technology Co Ltd, China Pharmaceutical University Arthritis, Rheumatoid; Rheumatic Diseases Details
Risuteganib ALG-1001 Phase 2 Clinical Allegro Ophthalmics Retinal Diseases; Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration Details
99mTc-3PRGD2 99mTc-3PRGD2 Phase 3 Clinical Peking University Contrast agents; Lymphatic Metastasis; Lung Neoplasms Details
ProAgio Phase 1 Clinical National Cancer Institute Pancreatic Neoplasms Details
[68Ga]-FF58 Phase 1 Clinical Glioblastoma; Brain Neoplasms Details

This web search service is supported by Google Inc.

totop